|
Volumn 18, Issue 1, 1996, Pages 50-52
|
Double-blind, placebo-controlled, cross-over trial of allopurinol as add-on therapy in childhood refractory epilepsy
a a |
Author keywords
Allopurinol; Anticonvulsant; Clinical trial; Hypouricemic drug; Refractory epilepsy
|
Indexed keywords
ALLOPURINOL;
ANTICONVULSIVE AGENT;
CARBAMAZEPINE;
CLOBAZAM;
CLONAZEPAM;
ETHOSUXIMIDE;
PHENOBARBITAL;
PYRIMIDINONE DERIVATIVE;
URIC ACID;
VALPROIC ACID;
ADJUVANT CHEMOTHERAPY;
ADOLESCENT;
ADULT;
ARTICLE;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG TOLERANCE;
EPILEPSY;
FOLLOW UP;
HUMAN;
ORAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
SEIZURE;
SIDE EFFECT;
TREATMENT OUTCOME;
URIC ACID BLOOD LEVEL;
|
EID: 0030043880
PISSN: 03877604
EISSN: None
Source Type: Journal
DOI: 10.1016/0387-7604(95)00110-7 Document Type: Article |
Times cited : (9)
|
References (10)
|